SIOG2024-1-OA-001 Randomized phase II study of Gemcitabine/Nab-Paclitaxel compared with 5-Fluorouracil/Leucovorin/Liposomal Irinotecan in older patients with treatment-naïve metastatic pancreatic cancer (GIANT EA2186)
Titel:
SIOG2024-1-OA-001 Randomized phase II study of Gemcitabine/Nab-Paclitaxel compared with 5-Fluorouracil/Leucovorin/Liposomal Irinotecan in older patients with treatment-naïve metastatic pancreatic cancer (GIANT EA2186)
Auteur:
Dotan, E. Catalano, P. Lenchik, L. Boutin, R. Yao, X. Ohr, J.P. Lim, K.-H. Vijayvergia, N. Chandana, S.R. Kalyan, A. Dunne, R.F. Zhen, D.B. Li, D. Simon, M.A. Berlin, J. Wagner, L.I. O'Dwyer, P.J.